BioChaperone^TM technology offers therapeutic opportunities in areas of high unmet medical needs such as:

• Diabetic foot ulcers
• Venous ulcers
• Osteoporosis
• Degenerative disc disease
• Non-union fractures

Adocia is looking for partnering its different projects to Companies with a high level of motivation for regenerative medicine.

For more information on the licensing opportunities with Adocia, you are kindly requested to contact Adocia’s Chief Executive Officer, Gérard Soula.